Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression. 2020

Eun-Sang Hwang, and Hyun-Bum Kim, and Seok Lee, and Min-Jeong Kim, and Kwan-Joong Kim, and Gaeul Han, and Se-Young Han, and Eun-A Lee, and Jeong-Hee Yoon, and Dae-Ok Kim, and Sungho Maeng, and Ji-Ho Park
Department of Gerontology, Graduate School of East-West Medical Science, Kyung Hee University, Deogyeong-daero, Giheung-gu, Yongin, 446-701, Republic of Korea.

Chronic stress is depressogenic by altering neurotrophic and neuroinflammatory environments of the organism. The endocannabinoid system controls cognitive and emotional responses related with stress through the interaction with endocannabinoid receptors. β-Caryophyllene (BCP) is a CB2 agonist that exhibited anti-inflammatory, analgesic effects but minimal psychoactive effects. To test if BCP exhibits antidepressant-like action, animals were chronically restrained with additional stressors for 28 days, and BCP (25, 50, 100 mg/kg) was intraperitoneally injected once a day during the stress inflicting period. Then despair related behaviors and hippocampal expression of neurotrophic, inflammatory and cannabinoid receptor levels were measured. To test the effect of BCP on long-term depression, field potentials were measured during the application of lipopolysaccharide and low frequency stimulation. In the tail suspension test and forced swim test, chronic stress-induced despair behaviors were reduced by BCP. Also BCP improved the stress-related changes in the hippocampal expression of COX-2, BDNF, and CB2 receptor expression. In organotypic hippocampal slices, BCP reduced the lipopolysaccharide-induced intensification of the long-term depression. In conclusion, BCP improved chronic stress related behavioral and biochemical changes. These results suggest that BCP may be effective in treating depression and stress related mental illnesses.

UI MeSH Term Description Entries
D008297 Male Males
D012149 Restraint, Physical Use of a device for the purpose of controlling movement of all or part of the body. Splinting and casting are FRACTURE FIXATION. Immobilization, Physical,Physical Restraint,Physical Immobilization,Physical Restraints,Restraints, Physical
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000081223 Polycyclic Sesquiterpenes Sesquiterpenes that contain two or more ring structures Caryophyllane,Caryophyllane Derivative,Caryophyllane Derivatives,Caryophyllanes,Eremophilane,Eremophilane Derivative,Eremophilane Derivatives,Eremophilanes,Polycyclic Sesquiterpene,Valerane,Valerane Derivative,Valerane Derivatives,Valeranes,Derivative, Caryophyllane,Derivative, Eremophilane,Derivative, Valerane,Derivatives, Caryophyllane,Derivatives, Eremophilane,Derivatives, Valerane,Sesquiterpene, Polycyclic,Sesquiterpenes, Polycyclic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D013315 Stress, Psychological Stress wherein emotional factors predominate. Cumulative Stress, Psychological,Emotional Stress,Individual Stressors,Life Stress,Psychological Cumulative Stress,Psychological Stress Experience,Psychological Stress Overload,Psychologically Stressful Conditions,Stress Experience, Psychological,Stress Measurement, Psychological,Stress Overload, Psychological,Stress Processes, Psychological,Stress, Emotional,Stressful Conditions, Psychological,Psychological Stress,Stress, Psychologic,Stressor, Psychological,Condition, Psychological Stressful,Condition, Psychologically Stressful,Conditions, Psychologically Stressful,Cumulative Stresses, Psychological,Experience, Psychological Stress,Individual Stressor,Life Stresses,Measurement, Psychological Stress,Overload, Psychological Stress,Psychologic Stress,Psychological Cumulative Stresses,Psychological Stress Experiences,Psychological Stress Measurement,Psychological Stress Measurements,Psychological Stress Overloads,Psychological Stress Processe,Psychological Stress Processes,Psychological Stresses,Psychological Stressful Condition,Psychological Stressful Conditions,Psychological Stressor,Psychological Stressors,Psychologically Stressful Condition,Stress Experiences, Psychological,Stress Processe, Psychological,Stress, Life,Stress, Psychological Cumulative,Stressful Condition, Psychological,Stressful Condition, Psychologically,Stressor, Individual

Related Publications

Eun-Sang Hwang, and Hyun-Bum Kim, and Seok Lee, and Min-Jeong Kim, and Kwan-Joong Kim, and Gaeul Han, and Se-Young Han, and Eun-A Lee, and Jeong-Hee Yoon, and Dae-Ok Kim, and Sungho Maeng, and Ji-Ho Park
January 2018, CNS & neurological disorders drug targets,
Eun-Sang Hwang, and Hyun-Bum Kim, and Seok Lee, and Min-Jeong Kim, and Kwan-Joong Kim, and Gaeul Han, and Se-Young Han, and Eun-A Lee, and Jeong-Hee Yoon, and Dae-Ok Kim, and Sungho Maeng, and Ji-Ho Park
September 2022, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Eun-Sang Hwang, and Hyun-Bum Kim, and Seok Lee, and Min-Jeong Kim, and Kwan-Joong Kim, and Gaeul Han, and Se-Young Han, and Eun-A Lee, and Jeong-Hee Yoon, and Dae-Ok Kim, and Sungho Maeng, and Ji-Ho Park
July 2021, Experimental and therapeutic medicine,
Eun-Sang Hwang, and Hyun-Bum Kim, and Seok Lee, and Min-Jeong Kim, and Kwan-Joong Kim, and Gaeul Han, and Se-Young Han, and Eun-A Lee, and Jeong-Hee Yoon, and Dae-Ok Kim, and Sungho Maeng, and Ji-Ho Park
January 2015, Evidence-based complementary and alternative medicine : eCAM,
Eun-Sang Hwang, and Hyun-Bum Kim, and Seok Lee, and Min-Jeong Kim, and Kwan-Joong Kim, and Gaeul Han, and Se-Young Han, and Eun-A Lee, and Jeong-Hee Yoon, and Dae-Ok Kim, and Sungho Maeng, and Ji-Ho Park
April 2010, Neuroscience bulletin,
Eun-Sang Hwang, and Hyun-Bum Kim, and Seok Lee, and Min-Jeong Kim, and Kwan-Joong Kim, and Gaeul Han, and Se-Young Han, and Eun-A Lee, and Jeong-Hee Yoon, and Dae-Ok Kim, and Sungho Maeng, and Ji-Ho Park
December 2010, Pharmacology, biochemistry, and behavior,
Eun-Sang Hwang, and Hyun-Bum Kim, and Seok Lee, and Min-Jeong Kim, and Kwan-Joong Kim, and Gaeul Han, and Se-Young Han, and Eun-A Lee, and Jeong-Hee Yoon, and Dae-Ok Kim, and Sungho Maeng, and Ji-Ho Park
January 1990, Polish journal of pharmacology and pharmacy,
Eun-Sang Hwang, and Hyun-Bum Kim, and Seok Lee, and Min-Jeong Kim, and Kwan-Joong Kim, and Gaeul Han, and Se-Young Han, and Eun-A Lee, and Jeong-Hee Yoon, and Dae-Ok Kim, and Sungho Maeng, and Ji-Ho Park
October 2020, Behavioural brain research,
Eun-Sang Hwang, and Hyun-Bum Kim, and Seok Lee, and Min-Jeong Kim, and Kwan-Joong Kim, and Gaeul Han, and Se-Young Han, and Eun-A Lee, and Jeong-Hee Yoon, and Dae-Ok Kim, and Sungho Maeng, and Ji-Ho Park
March 2017, Behavioural brain research,
Eun-Sang Hwang, and Hyun-Bum Kim, and Seok Lee, and Min-Jeong Kim, and Kwan-Joong Kim, and Gaeul Han, and Se-Young Han, and Eun-A Lee, and Jeong-Hee Yoon, and Dae-Ok Kim, and Sungho Maeng, and Ji-Ho Park
January 2023, Frontiers in pharmacology,
Copied contents to your clipboard!